In hepatocellular carcinoma, GSTZ1 exerts tumor-suppressive effects: its downregulation leads to succinylacetone accumulation, activating the NRF2 signaling pathway and thereby promoting hepatocellular carcinoma progression [79, 80]. Here, GSTZ1 is linked to hepatocellular carcinoma.